What is the appropriate dose of ferrous bisglycinate for a 5‑year‑old girl weighing 14.5 kg with iron‑deficiency anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ferrous Bisglycinate Dosing for Iron Deficiency Anemia in a 5-Year-Old Child

For a 5-year-old girl weighing 14.5 kg with iron deficiency anemia, prescribe 3 mg/kg/day of elemental iron as ferrous bisglycinate, which equals approximately 43.5 mg elemental iron daily, administered between meals for optimal absorption. 1

Dosing Calculation and Administration

  • The Centers for Disease Control and Prevention recommends 3 mg/kg/day of elemental iron for treating iron deficiency anemia in children 1
  • For this 14.5 kg child: 3 mg/kg × 14.5 kg = 43.5 mg elemental iron daily 1
  • Administer the dose between meals (not with food or milk), as food reduces iron absorption by up to 50% 1
  • Ferrous bisglycinate has demonstrated 90.9% bioavailability compared to 26.7% for ferrous sulfate, meaning lower doses may achieve equivalent therapeutic effect 2

Why Ferrous Bisglycinate Is Appropriate

  • Ferrous bisglycinate chelate shows superior efficacy in increasing both hemoglobin and ferritin levels compared to polymaltose iron in pediatric studies 3
  • The chelated form exhibits excellent tolerability with a low incidence of gastrointestinal side effects, improving adherence in young children 3, 2
  • Research demonstrates that ferrous bisglycinate absorption is regulated by body iron demand, with greater uptake in children with lower baseline hemoglobin levels 3, 2
  • One study showed ferrous bisglycinate significantly increased ferritin and mean corpuscular hemoglobin levels, while polymaltose iron did not 3

Treatment Duration and Monitoring

  • Recheck hemoglobin after 4 weeks of therapy to confirm treatment response 1
  • An increase of ≥1 g/dL hemoglobin (or ≥3% hematocrit) after 4 weeks confirms adequate response and validates the diagnosis of iron deficiency anemia 1
  • Continue treatment for 2–3 months after hemoglobin normalizes to fully replenish iron stores 1
  • Total treatment duration is typically 3–4 months from initiation 4

Dietary Counseling to Enhance Treatment

  • Limit cow's milk intake to maximum 24 ounces daily, as excessive milk consumption is a major contributor to iron deficiency in children 1
  • Encourage vitamin C-rich foods (citrus fruits, tomatoes, bell peppers) with iron doses to enhance absorption 5, 1
  • Introduce iron-fortified cereals (two or more servings daily) and iron-rich foods such as meat, poultry, and fish 1
  • Avoid administering iron with calcium-containing foods or supplements, as calcium interferes with iron absorption 5

Critical Pitfalls to Avoid

  • Do not administer with meals or milk: This is the most common error that dramatically reduces bioavailability 1
  • Do not discontinue prematurely: Stopping iron when hemoglobin normalizes fails to restore iron stores; the additional 2–3 months is essential 4, 1
  • Monitor for iron overload with prolonged use: Although rare, amino acid chelated iron can cause secondary iron overload if used beyond one year without monitoring ferritin levels 6
  • Check ferritin if treatment extends beyond 3–4 months: Even asymptomatic patients may develop iron accumulation with prolonged supplementation 6

When to Escalate Care

  • If hemoglobin rises by <1 g/dL after 4 weeks despite documented adherence, obtain additional testing including mean corpuscular volume, red cell distribution width, and serum ferritin 4
  • A serum ferritin ≥15 µg/L after inadequate response suggests an alternative etiology and warrants further investigation 4, 1
  • Consider hematology referral if the cause of anemia remains unclear after extended testing or if there is no response to appropriate iron therapy 4

Practical Considerations

  • Ferrous bisglycinate is available in liquid formulations suitable for young children, making administration easier than tablets 2
  • The higher bioavailability of ferrous bisglycinate means that even if the child misses occasional doses, therapeutic effect is more likely maintained compared to conventional iron salts 2
  • Side effects (nausea, constipation, dark stools) are significantly lower with ferrous bisglycinate than with ferrous sulfate, improving long-term adherence 3, 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.